GlassScriptPhysician profile
Mark H Getelman
NPI 1275569832
$279,714.27
in general payments reported to CMS, 2019-2025
19 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $71K · 2021: $53K · 2022: $33K · 2023: $41K · 2024: $27K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Royalty Or License: $20K · Food and Beverage: $2,222 · Travel and Lodging: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,709.50 |
| Royalty Or License | $19,795.72 |
| Food and Beverage | $2,221.61 |
| Travel and Lodging | $1,387.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $168,730.18 | 2019-2025 | Na |
| Depuy Synthes Products, INC. | $79,841.28 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $13,022.96 | 2023-2024 | Tapestry, Juggerknotless Soft Anchor |
| Maruho Medical, INC. | $8,971.65 | 2019-2022 | |
| Pristine Surgical LLC | $5,000.00 | 2024 | Summit Arthroscope |
| Depuy Synthes Sales INC. | $2,664.83 | 2019-2025 | Healix Knotless Peek, Twistr, Na |
| Smith+Nephew, INC. | $346.37 | 2019-2025 | Double Pump Rf, Q-Fix, 660hd-E Image Management System |
| Linvatec Corporation | $252.01 | 2019-2023 | Livatec Knee Preservation System, Biobrace 23mm |
| Electronic Waveform Lab, INC. | $225.61 | 2023-2025 | |
| Spr Therapeutics, INC | $185.44 | 2023 | Sprint Pns System |
| Arthrex, INC. | $99.90 | 2020 | |
| Vericel Corporation | $84.89 | 2020-2023 | Maci |
| Pacira Therapeutics, INC. | $80.73 | 2019-2020 | |
| Encore Medical, LP | $71.98 | 2019 | |
| Stryker Corporation | $41.59 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $36.52 | 2025 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $26.56 | 2019 | |
| Heron Therapeutics, INC. | $18.84 | 2025 | Zynrelef |
| Innovation Technologies INC | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$39,266.68 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Getelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.